Pharmaceutical News

RSS

Astrazeneca, Taiwan's NRPB Launch Drug Discovery Collaboration

...

18 Oct 2013

FDA approves Cimzia for treatment of adults with active ankylosing spondylitis

UCB announced today that the U.S. Food and Drug Administration has approved Cimzia (certolizumab pegol) for the treatment of adults with active ankylosing spondylitis.

18 Oct 2013

pSivida reports that Alimera Sciences gets FDA Complete Response Letter for ILUVIEN NDA

pSivida Corp., a specialty pharmaceutical company that is a leader in developing sustained release drugs for treatment of back-of-the-eye diseases, today announced that its licensee Alimera Sciences, Inc. has received a Complete Response Letter for the New Drug Application for ILUVIEN from the U.S. Food and Drug Administration.

18 Oct 2013

European Commission approves updated label of Prevenar 13 for high risk pneumococcal disease

Pfizer Inc. (NYSE:PFE) announced today that the European Commission approved updates to the Summary of Product Characteristics (SmPC) for the company's pneumococcal conjugate vaccine Prevenar 13* (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), regarding its use in certain populations at high risk of pneumococcal disease.

18 Oct 2013

Altherx Pharmaceuticals receives U.S. patent for use of solabegron for treatment of overactive bladder

AltheRx Pharmaceuticals, a privately-held clinical development company, today announced the United States Patent and Trademark Office issued a Notice of Allowance for the company's U.S. Patent Application claiming a method of use for solabegron, a beta 3-adrenergic receptor agonist, in combination with all commercially available antimuscarinics at both therapeutic and sub-therapeutic doses for the treatment of overactive bladder (OAB).

18 Oct 2013

New article in Preventive Medicine journal explores suspicions about sexual promiscuity, vaccine safety

Suspicions about sexual promiscuity and vaccine safety are explored in an article in the November issue of the journal Preventive Medicine, which dedicates a section of that issue to research concerning the human papillomavirus.

18 Oct 2013

Two drugs in combination improve survival in patients with advanced pancreatic cancer

Investigators at the Vall d´Hebron University Hospital and the Vall d'Hebron Institute of Oncology (VHIO), have participated in an international phase III study, published in The New England Journal of Medicine.

18 Oct 2013

Study finds no relevant association between Vitamin D serum level and incidence of kidney stones

Increased vitamin D levels may prevent a wide range of diseases, according to recent studies. However, some previous studies led to a concern that vitamin D supplementation could increase an individual's risk of developing kidney stones.

18 Oct 2013

Use of effective, risky drug therapies by Medicare patients varies across US

A new report from the Dartmouth Atlas Project shows that the use of both effective and risky drug therapies by Medicare patients varies widely across U.S. regions, offering further evidence that location is a key determinant in the quality and cost of the medical care that patients receive.

18 Oct 2013

Atorvastatin drug plus zoledronic acid may help treat toxoplasmosis

Researchers at the University of Georgia have discovered that a combination of two commonly prescribed drugs used to treat high cholesterol and osteoporosis may serve as the foundation of a new treatment for toxoplasmosis, a parasitic infection caused by the protozoan Toxoplasma gondii. They published their findings recently in PLOS Pathogens.

18 Oct 2013

Jain Foundation Steps Up Efforts To Find Cure For Muscular Dystrophy

...

17 Oct 2013

High long-chain omega-3 polyunsaturated fatty acid content may lower risk of brain abnormalities

According to a new study, high long-chain omega-3 polyunsaturated fatty acid content in blood may lower the risk of small brain infarcts and other brain abnormalities in the elderly.

17 Oct 2013

Use of antibiotics to treat catheter-associated bacteriuria infection show no change in mortality rates

With 30 million indwelling bladder catheters placed annually nationwide, patients face an increased risk of developing catheter-associated bacteriuria (bacteria in the urine). Many patients with indwelling urinary catheters acquire bacteria in the urinary tract while they are catheterized.

17 Oct 2013

Using mobile device to check drug info prevents adverse events, say nursing home doctors

Nearly nine out of 10 nursing home physicians said that using their mobile devices to look up prescription drug information prevented at least one adverse drug event in the previous month, according to a University of Pittsburgh School of Medicine Department of Biomedical Informatics study published last week in the Journal of the American Medical Directors Association.

17 Oct 2013

Nintedanib drug to treat NSCLC is submitted for approval from European Medicines Agency

Boehringer Ingelheim announced the submission of a Marketing Authorisation Application to the European Medicines Agency for the approval of its oral triple angiokinase inhibitor nintedanib, in combination with docetaxel, for the treatment of patients with locally advanced, metastatic or recurrent non-small cell lung cancer (NSCLC) of adenocarcinoma tumour histology after first line chemotherapy.

17 Oct 2013

Researchers find novel drug target for anaplastic thyroid carcinomas

Anaplastic thyroid carcinomas are aggressive tumors that do not respond to traditional radio- or chemotherapeutic agents, and there currently is no cure or effective treatment available. Median survival from diagnosis is 5 months, and although ATC accounts for only 1.7% of all thyroid cancers in the U.S., it is responsible for a large proportion of thyroid cancer-related deaths.

17 Oct 2013

Pharmaceutical News

Astrazeneca, Taiwan's NRPB Launch Drug Discovery Collaboration

FDA approves Cimzia for treatment of adults with active ankylosing spondylitis

pSivida reports that Alimera Sciences gets FDA Complete Response Letter for ILUVIEN NDA

European Commission approves updated label of Prevenar 13 for high risk pneumococcal disease

Altherx Pharmaceuticals receives U.S. patent for use of solabegron for treatment of overactive bladder

New article in Preventive Medicine journal explores suspicions about sexual promiscuity, vaccine safety

Two drugs in combination improve survival in patients with advanced pancreatic cancer

Study finds no relevant association between Vitamin D serum level and incidence of kidney stones

Use of effective, risky drug therapies by Medicare patients varies across US

Atorvastatin drug plus zoledronic acid may help treat toxoplasmosis

Jain Foundation Steps Up Efforts To Find Cure For Muscular Dystrophy

High long-chain omega-3 polyunsaturated fatty acid content may lower risk of brain abnormalities

Use of antibiotics to treat catheter-associated bacteriuria infection show no change in mortality rates

Using mobile device to check drug info prevents adverse events, say nursing home doctors

Nintedanib drug to treat NSCLC is submitted for approval from European Medicines Agency

Researchers find novel drug target for anaplastic thyroid carcinomas

Certain blood pressure medications may reduce risk of dementia due to Alzheimer's disease

Jain Foundation Steps Up Efforts To Find Cure For Muscular Dystrophy

Pieris Inks Co-Development Deal With Zydus For Protein Drugs

Astrazeneca To Use Wyss Institute’s Organs-On-Chips

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News